Bookmark and Share

Compound Summary for: CID 54671008

raltegravir

Also known as: Isentress; 518048-05-0; MK-0518; Isentress(TM); UNII-22VKV8053U; S2005_Selleck; MK 0518; CHEMBL254316; MK-518
Molecular Formula: C20H21FN6O5   Molecular Weight: 444.416343   InChIKey: CZFFBEXEKNGXKS-UHFFFAOYSA-N
Raltegravir is an antiretroviral drug produced by Merck & Co., used to treat HIV infection. It received approval by the U.S. Food and Drug Administration (FDA) on 12 October 2007, the first of a new class of HIV drugs, the integrase inhibitors, to receive such approval. [Wikipedia]   From: DrugBank
Show subcontent titlesTable of Contents
Identification
Related Records
show all 3 sub-sections (Related Compounds with Annotation, Related Compounds, Related Substances)
Use and Manufacturing
Pharmacology
Biomedical Effects and Toxicity
Safety and Handling
Environmental Fate and Exposure Potential
Exposure Standards and Regulations
Literature
Patents
Biomolecular Interactions and Pathways
Biological Test Results
Classification
Chemical and Physical Properties
_ _